PE
1985
$10 000 M
New York City, New York, United States
Investment Ticket
Investment Horizon
Investment Stage
Exit Strategy
Profile
Invus has been empowering entrepreneurs to transform their industries since 1985. We have a continuous capital structure with over $10 billion under management and offices in the U.S., Europe and Asia. We focus on investments in consumer, technology and life sciences.
We know what it takes to transform an industry: strategic insight, capital that isn't on an arbitrary exit schedule and world-class execution. We partner with entrepreneurs and their teams on all three of these dimensions. Invus offers the best of both worlds: The time horizon and personal attention of a bespoke family office with the professionalism and capabilities of a world-class multi-strategy firm.
In addition to investing in private companies, we have been investing in public companies since 2004, where we take significant, long-term positions.
We have been running a fund-of-funds strategy since 1994 with a particular expertise and focus in emergin/early-stage hedge fund managers.
We welcome you to visit our website and learn more about Invus.
Industry
Region of investment
The Invus Group Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Invus Opportunities Fund
|
Private Equity (PE)
|
Biotechnology
Consumer Products
Consumer Services (B2C)
Financial Services
Healthcare Services
Media and Entertainment
SaaS
Technology
|
Series B
Late Stage (Series C+)
|
North America
Europe
|
$5-10 m
|
$2500 M
|
June 2016
|